BR0314212A - Projeto de análogos de quimiocina para o tratamento de doenças humanas - Google Patents

Projeto de análogos de quimiocina para o tratamento de doenças humanas

Info

Publication number
BR0314212A
BR0314212A BR0314212-4A BR0314212A BR0314212A BR 0314212 A BR0314212 A BR 0314212A BR 0314212 A BR0314212 A BR 0314212A BR 0314212 A BR0314212 A BR 0314212A
Authority
BR
Brazil
Prior art keywords
analogs
treatment
chemokine
human diseases
project
Prior art date
Application number
BR0314212-4A
Other languages
English (en)
Other versions
BR0314212C1 (pt
Inventor
Ahmed Merzouk
Donald Wong
Hassan Salari
Original Assignee
Chemokine Therapeutics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemokine Therapeutics Corp filed Critical Chemokine Therapeutics Corp
Publication of BR0314212A publication Critical patent/BR0314212A/pt
Publication of BR0314212C1 publication Critical patent/BR0314212C1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4718—Cytokine-induced proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5421—IL-8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"PROJETO DE ANáLOGOS DE QUIMIOCINA PARA O TRATAMENTO DE DOENCAS HUMANAS". A presente invenção se refere aos análogos de quimiocina, incluindo análogos IL-8, análogos IP-10, análogos MIP-l<244>, análogos RANTES, análogos I-309, análogos MCP-1 e análogos CCL28 que são úteis para o tratamento de várias doenças e transtornos e como um coadjuvante no tratamento de uma variedade de doenças e transtornos. Uma quantidade terapeuticamente eficaz do análogo de quimiocina pode ser administrada ao paciente que necessite de tal tratamento.
BRC10314212-4A 2002-09-13 2003-09-11 projeto de análogos a quimiocina de proteìna-10 (ip-10 ou cxcl10) induzìveis por interferon para o tratamento de doenças humanas BR0314212C1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/243,795 US7091310B2 (en) 2002-09-13 2002-09-13 Chemokine analogs for the treatment of human disease
PCT/US2003/028745 WO2004024088A2 (en) 2002-09-13 2003-09-11 Design of chemokine analogs for the treatment of human diseases

Publications (2)

Publication Number Publication Date
BR0314212A true BR0314212A (pt) 2005-07-19
BR0314212C1 BR0314212C1 (pt) 2008-03-11

Family

ID=31991735

Family Applications (1)

Application Number Title Priority Date Filing Date
BRC10314212-4A BR0314212C1 (pt) 2002-09-13 2003-09-11 projeto de análogos a quimiocina de proteìna-10 (ip-10 ou cxcl10) induzìveis por interferon para o tratamento de doenças humanas

Country Status (6)

Country Link
US (2) US7091310B2 (pt)
EP (2) EP1536834A4 (pt)
JP (2) JP2005539063A (pt)
BR (1) BR0314212C1 (pt)
CA (1) CA2498723A1 (pt)
WO (1) WO2004024088A2 (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002506830A (ja) 1998-03-13 2002-03-05 ザ ユニバーシティ オブ ブリティッシュ コロンビア 治療的ケモカイン受容体アンタゴニスト
CA2305787A1 (en) 2000-05-09 2001-11-09 The University Of British Columbia Cxcr4 antagonist treatment of hematopoietic cells
CA2245224A1 (en) 1998-08-14 2000-02-14 Jiang-Hong Giong Chemokine receptor antagonists and chemotherapeutics
US20050059584A1 (en) 2002-08-16 2005-03-17 Ahmed Merzouk Novel chemokine mimetics synthesis and their use
US20060233748A1 (en) * 2002-09-13 2006-10-19 Ahmed Merzouk Mimetics of interleukin-8 and methods of using them in the prevention, treatment, diagnosis, and ameliorization of symptoms of a disease
US7368425B2 (en) 2006-03-24 2008-05-06 Chemokine Therapeutics Corp. Cyclic peptides for modulating growth of neo-vessels and their use in therapeutic angiogenesis
JP2004196770A (ja) * 2002-10-24 2004-07-15 Effector Cell Institute Inc 樹状細胞前駆体の血中レベル上昇剤
EP1854474A4 (en) 2005-01-31 2012-04-04 Eci Inc IMMUNOSTIMULATING AGENT
CA2624138A1 (en) * 2005-09-29 2007-04-05 British Columbia Cancer Agency Branch Method and composition for increasing the engraftment efficiency of stem cells
CA2627939A1 (en) * 2005-12-15 2007-06-21 Laboratoires Serono S.A. New chemokine antagonists
WO2007079460A2 (en) * 2006-01-04 2007-07-12 Chemokine Therapeutics Corporation Design of cxc chemokine analogs for the treatment of human diseases
US20100113342A1 (en) * 2006-06-20 2010-05-06 Yount Nannette I Antimicrobial kinocidin compositions and methods of use
JP2008031143A (ja) * 2006-07-26 2008-02-14 Chemokine Therapeutics Corp ヒト疾患を治療するためのインターフェロン誘導性タンパク質−１０（ｉｐ−１０又はｃｘｃｌ１０）ケモカイン類縁体の設計
EP1882698A1 (en) * 2006-07-26 2008-01-30 Chemokine Therapeutics Corp. Design of interferon-inducible protein-10 (IP10 or CXCL10) chemokine analogs for the treatment of human diseases
US20080076120A1 (en) * 2006-09-14 2008-03-27 Millennium Pharmaceuticals, Inc. Methods for the identification, evaluation and treatment of patients having CC-Chemokine receptor 2 (CCR-2) mediated disorders
AU2009223784A1 (en) * 2008-03-08 2009-09-17 Immungene, Inc. Engineered fusion molecules immunotherapy in cancer and inflammatory diseases
WO2010129351A1 (en) 2009-04-28 2010-11-11 Schepens Eye Research Institute Method to identify and treat age-related macular degeneration
WO2011011733A2 (en) 2009-07-24 2011-01-27 The Regents Of The University Of Michigan Factor replacement therapy
AU2016210582B2 (en) 2015-01-22 2020-01-30 Ramakrishna Reddy Isanaka Peptide for treating inflammatory diseases
US20210300981A1 (en) * 2018-07-24 2021-09-30 University Of Virginia Patent Foundation Compositions and methods for combating multidrug-resistant bacteria
WO2021231648A2 (en) * 2020-05-12 2021-11-18 Gigagen, Inc. Cancer therapeutics comprising chemokine or its analog
WO2023213400A1 (en) * 2022-05-05 2023-11-09 Institute For Research In Biomedicine Antibodies against chemokines, method for identifying said antibodies and uses thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5401651A (en) 1991-10-16 1995-03-28 Walz; Alfred DNA encoding ENA-78, a neutrophil activating factor
DE69226649D1 (de) * 1991-12-04 1998-09-17 Biomedical Research Centre Ltd Analoge des menschlichen Interleukin-8.
WO1995035376A2 (en) * 1994-06-20 1995-12-28 Chiron Corporation Polypeptides with interleukin 8 receptor 1 (il8r1) binding domains
MXPA00003885A (es) * 1997-10-22 2004-04-23 Inst Genetics Llc Quimiocinas con modificiaciones de la terminacion amino.
CA2305787A1 (en) 2000-05-09 2001-11-09 The University Of British Columbia Cxcr4 antagonist treatment of hematopoietic cells
US6762341B2 (en) * 2000-02-10 2004-07-13 Schering Corporation Uses of mammalian CCR8 receptors and related reagents
US7378098B2 (en) 2000-04-12 2008-05-27 The University Of British Columbia CXC chemokine receptor 4 agonist peptides
US20060233748A1 (en) * 2002-09-13 2006-10-19 Ahmed Merzouk Mimetics of interleukin-8 and methods of using them in the prevention, treatment, diagnosis, and ameliorization of symptoms of a disease
CA2335109A1 (en) 2000-04-12 2001-10-12 Chemokine Therapeutics Corporation Cxcr4 agonist treatment of hematopoietic cells
US20050059584A1 (en) * 2002-08-16 2005-03-17 Ahmed Merzouk Novel chemokine mimetics synthesis and their use
JP2003532683A (ja) 2000-05-09 2003-11-05 ザ ユニバーシティ オブ ブリティッシュ コロンビア 造血細胞のｃｘｃｒ４アンタゴニスト治療
NZ523679A (en) * 2000-11-27 2005-10-28 Rmf Dictagene S Process for folding chemically synthesized polypeptides containing derivatised cysteine
US20030004136A1 (en) 2001-03-05 2003-01-02 Geeta Saxena IL-8 receptor ligands-drugs for inflammatory and autoimmune diseases
US6515001B2 (en) 2001-03-05 2003-02-04 Chemokine Therapeutic Corporation IL-8 receptor ligands-drugs for inflammatory and autoimmune diseases
US6693134B2 (en) 2001-05-29 2004-02-17 Chemokine Therapeutics Corporation Bicyclic aromatic chemokine receptor ligands
US20030092674A1 (en) 2001-06-14 2003-05-15 Geeta Saxena Tricyclic rantes receptor ligands
US6831101B2 (en) 2001-06-14 2004-12-14 Chemokine Therapeutics Corporation Tricyclic rantes receptor ligands

Also Published As

Publication number Publication date
US7091310B2 (en) 2006-08-15
EP1834961A2 (en) 2007-09-19
BR0314212C1 (pt) 2008-03-11
US20070066523A1 (en) 2007-03-22
WO2004024088A2 (en) 2004-03-25
US20040197303A1 (en) 2004-10-07
EP1536834A2 (en) 2005-06-08
JP2007106768A (ja) 2007-04-26
EP1834961A3 (en) 2008-06-11
WO2004024088A3 (en) 2005-02-24
JP2005539063A (ja) 2005-12-22
CA2498723A1 (en) 2004-03-25
EP1536834A4 (en) 2007-11-07

Similar Documents

Publication Publication Date Title
BR0314212A (pt) Projeto de análogos de quimiocina para o tratamento de doenças humanas
ATE450269T1 (de) Peptid pyyä3-36ü zur behandlung von stoffwechselkrankheiten
PT1448564E (pt) Composto do tipo indolizina substituidos e metodos de utilizacao
GB9902453D0 (en) Chemical compounds
DE60220887D1 (de) Agonisten von beta-adrenorezeptoren
EA200700118A1 (ru) Амидосоединения и их применение в качестве лекарственных средств
DK1309589T3 (da) Ureaforbindelser og anvendelsesfremgangsmåder
BR0310106A (pt) Composto, processo para a produção de um composto, composição farmacêutica, uso do composto e método para o tratamento de um sujeito em sofrimento de uma condição ou doença patalógica
BR0308429A (pt) Aroilpiridinonas monocìclicas como agentes antiinflamatórios
BR0208150A (pt) Antagonistas de mch e sua aplicação no tratamento da obesidade
EA200400971A1 (ru) Фторзамещенные циклоалканоиндолы, композиции, содержащие такие соединения, и способы лечения
MEP35308A (en) COMPOUNDS SPECIFIC TO ADENOSINE A1, A2a, AND A3 RECEPTOR AND USES THEREOF
DE60320095D1 (de) Zusammensetzungen zur behandlung von hauterkrankungen
BRPI0508927A (pt) compostos úteis para o tratamento de doenças
ATE516366T1 (de) Regulierte aptamer-therapeutika
EA200500803A1 (ru) Антагонисты ccr1 для лечения воспалительных артритов, демиелинизационных воспалительных заболеваний
SE0004101D0 (sv) New use
HUP0204551A2 (hu) Eljárás a pikkelysömör kezelésére
DE60220512D1 (de) Verwendung von flumazenil zur herstellung eines medikaments für die behandlung von kokainabhängigkeit
CY1107756T1 (el) Αναλογα θειου της 21-υδροξυ-6, 19-οξειδοπρογεστερονης (21oh-6οp) για τη θεραπεια πλεονασματος γλυκοκορτικοειδων
ITMI20031144A1 (it) Analoghi del colchicoside.
UY26179A1 (es) Amidas sustituidas del ácido fenilciclohexanocarboxilico y su uso como inhibidores de la incorporación de adenosina.
ATE458495T1 (de) Therapeutische zubereitung für autoimmune erkrankungen
SE0100873D0 (sv) Method of treatment
UY27475A1 (es) Amidas de ácido piperazinciclohexanocarboxílico sustituidas y su utilización

Legal Events

Date Code Title Description
B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]

Free format text: ADDITIONAL INVENTOR S CERTIFICATE:

B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A E 7A ANUIDADES.

B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing

Free format text: ADDITIONAL INVENTOR S CERTIFICATE:

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2069 DE 31/08/2010.

B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired

Free format text: ADDITIONAL INVENTOR S CERTIFICATE: